Get the Stockscreener App
8.76
2.99%
-0.27
After Hours:
8.77
0.010
+0.11%
Fennec Pharmaceuticals Inc stock is traded at $8.76, with a volume of 40,100.
It is down -2.99% in the last 24 hours and down -5.19% over the past month.
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.
See More
Previous Close:
$9.03
Open:
$8.99
24h Volume:
40,100
Relative Volume:
0.63
Market Cap:
$244.50M
Revenue:
$21.25M
Net Income/Loss:
$-16.05M
P/E Ratio:
-14.36
EPS:
-0.61
Net Cash Flow:
$-17.14M
1W Performance:
-2.67%
1M Performance:
-5.19%
6M Performance:
+34.77%
1Y Performance:
+62.52%
1-Day Range:
$8.655
$9.13
1-Week Range:
$8.655
$9.23
52-Week Range:
$3.96
$9.42
Fennec Pharmaceuticals Inc Stock (FENC) Company Profile
Name
Fennec Pharmaceuticals Inc
Sector
Industry
Phone
(919) 636-4530
Address
PO BOX 13628, RESEARCH TRIANGLE PARK, NC
Compare FENC with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
FENC
Fennec Pharmaceuticals Inc
|
8.76 | 250.76M | 21.25M | -16.05M | -17.14M | -0.61 |
|
VRTX
Vertex Pharmaceuticals Inc
|
394.53 | 99.62B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
465.89 | 61.52B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.00 | 58.91B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
756.38 | 46.69B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
324.34 | 34.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Fennec Pharmaceuticals Inc Stock (FENC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-22-22 | Upgrade | Cantor Fitzgerald | Neutral → Overweight |
| Sep-07-22 | Initiated | CapitalOne | Overweight |
| Aug-08-22 | Resumed | Craig Hallum | Buy |
| Jun-05-20 | Initiated | Cantor Fitzgerald | Overweight |
| Oct-11-18 | Initiated | Goldman | Buy |
Fennec Pharmaceuticals Inc Stock (FENC) Latest News
Can Fennec Pharmaceuticals Inc. recover in the next quarterPortfolio Return Summary & Capital Protection Trade Alerts - Newser
Can a trend reversal in Fennec Pharmaceuticals Inc. lead to recoveryPortfolio Gains Report & Proven Capital Preservation Methods - Newser
Real time breakdown of Fennec Pharmaceuticals Inc. stock performanceTrade Exit Summary & Free Safe Entry Trade Signal Reports - Newser
Fennec Pharmaceuticals Inc. stock prediction for this weekPortfolio Performance Report & Long-Term Growth Portfolio Plans - Newser
Will Fennec Pharmaceuticals Inc. bounce back from current supportMarket Sentiment Review & Free High Return Stock Watch Alerts - Newser
Tools to monitor Fennec Pharmaceuticals Inc. recovery probabilityQuarterly Earnings Report & AI Based Buy/Sell Signal Reports - Newser
Applying big data sentiment scoring on Fennec Pharmaceuticals Inc.Portfolio Return Report & Detailed Earnings Play Alerts - Newser
Visual analytics tools that track Fennec Pharmaceuticals Inc. performance2025 Market Sentiment & AI Optimized Trade Strategies - Newser
How to build a custom watchlist for Fennec Pharmaceuticals Inc.Market Activity Recap & Real-Time Stock Entry Alerts - Newser
Published on: 2025-09-12 05:33:49 - Newser
MetLife Investment Management LLC Has $73,000 Holdings in Adherex Technologies Inc. $FENC - Defense World
Comparing Fennec Pharmaceuticals Inc. in custom built stock radarsRisk Management & Real-Time Volume Analysis Alerts - Newser
fennec pharmaceuticals inc. stock prediction for this week2025 Volume Leaders & Advanced Swing Trade Entry Alerts - Newser
Can technical indicators confirm Fennec Pharmaceuticals Inc.’s reversalWeekly Trading Summary & Weekly Return Optimization Plans - Newser
Visualizing Fennec Pharmaceuticals Inc. stock with heatmapsJuly 2025 Sentiment & Fast Gain Swing Alerts - Newser
Real time scanner hits for Fennec Pharmaceuticals Inc. explained2025 Breakouts & Breakdowns & Weekly Market Pulse Updates - Newser
What momentum shifts mean for Fennec Pharmaceuticals Inc.Stock Surge & Expert Curated Trade Setups - Newser
What Fibonacci levels say about Fennec Pharmaceuticals Inc. reboundPortfolio Return Summary & Real-Time Buy Signal Notifications - Newser
Fennec Pharmaceuticals (TSE:FRX) Stock Crosses Above 50 Day Moving AverageHere's What Happened - MarketBeat
Real time alert setup for Fennec Pharmaceuticals Inc. performanceWeekly Trend Recap & Real-Time Buy Signal Alerts - Newser
How hedge fund analytics apply to Fennec Pharmaceuticals Inc. stockSell Signal & Stock Market Timing Techniques - Newser
Combining machine learning predictions for Fennec Pharmaceuticals Inc.Earnings Performance Report & Risk Managed Trade Strategies - Newser
Is Fennec Pharmaceuticals Inc. a candidate for recovery playMarket Weekly Review & Daily Volume Surge Signals - Newser
Fennec Pharmaceuticals at H.C. Wainwright: Steady Growth and Strategic Expansion - Investing.com Canada
Using data models to predict Fennec Pharmaceuticals Inc. stock movementMarket Volume Report & Daily Entry Point Trade Alerts - Newser
Is this a good reentry point in Fennec Pharmaceuticals Inc.July 2025 Sector Moves & Stepwise Trade Execution Plans - Newser
Fennec Pharmaceuticals Inc Stock (FENC) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):